IMFINZI (Durvalumab) 500 mg Injection
IMFINZI Durvalumab 500 mg Injection is an immunotherapy medicine used in the treatment of certain types of cancers. It contains Durvalumab, a programmed death-ligand 1 (PD-L1) inhibitor that helps the immune system recognize and attack cancer cells more effectively. It is commonly used in cancers such as non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and certain biliary tract cancers.
By blocking PD-L1, IMFINZI helps restore immune response against tumor cells, slowing disease progression and improving survival outcomes in eligible patients.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition and Content
- Active Ingredient: Durvalumab
- Strength: 500 mg per vial
- Dosage Form: Intravenous (IV) infusion
- Drug Class: Immune checkpoint inhibitor (PD-L1 inhibitor monoclonal antibody)
How It Works
IMFINZI works by:
- Blocking PD-L1 protein on cancer cells
- Enhancing immune system activity against tumors
- Preventing cancer cells from escaping immune detection
- Helping the body destroy cancer cells naturally
Uses and Treatments
IMFINZI (Durvalumab) Injection is used for:
- Non-Small Cell Lung Cancer (NSCLC)
- Extensive Stage Small Cell Lung Cancer (SCLC)
- Biliary Tract Cancer (in combination therapies)
- Bladder and urothelial cancers (in specific cases)
- Maintenance therapy after chemoradiation in lung cancer
Dosage and How to Use
- Administered as intravenous infusion in hospital setting
- Given every 2–4 weeks depending on treatment protocol
- Dosage is calculated by oncologist based on body weight and condition
- Must be administered under strict medical supervision
Important: Only trained oncology professionals should administer this medicine.
Advantages of IMFINZI (Durvalumab)
- Boosts immune system’s ability to fight cancer
- Improves survival in certain advanced cancers
- Used as maintenance therapy after chemotherapy/radiation
- Targeted immunotherapy with precision mechanism
- Can delay cancer progression in eligible patients
Storage Conditions
- Store at 2°C to 8°C (refrigerated)
- Do not freeze
- Keep in original packaging to protect from light
- Do not shake vial
- Use only under medical supervision in clinical setting
Alternative Indian Brands / Options
Durvalumab is a patented biologic immunotherapy, so direct Indian generic versions are not widely available. However, alternative immune checkpoint inhibitors used in similar cancer treatments include:
- Keytruda (Pembrolizumab) by Merck & Co.
- Opdivo (Nivolumab) by Bristol Myers Squibb
- Tecentriq (Atezolizumab) by Roche
- Indian oncology biosimilars from Dr. Reddy’s Laboratories
All alternatives must be selected strictly by an oncologist based on cancer type and stage.
Buy IMFINZI Durvalumab 500 mg Injection Online in India – Trusted Oncology Medicine Exporter
Looking to buy IMFINZI Durvalumab 500 mg Injection in India? GlobMedIndia is a trusted international medicine exporter of oncology and immunotherapy drugs, offering safe, genuine, and high-quality cancer medicines with secure supply across India.
We specialize in providing advanced immunotherapy and checkpoint inhibitor medicines used in modern cancer treatment protocols.
Why Choose GlobMedIndia?
- Trusted exporter of oncology medicines
- Fast and secure supply chain
- 100% genuine pharmaceutical products
- Reliable global healthcare sourcing
- Expert support for hospital and patient needs
- Buy Durvalumab 500 mg India
- IMFINZI injection price India
- Lung cancer immunotherapy India
- PD-L1 inhibitor medicine India
- Cancer immunotherapy injection India
- Oncology medicine exporter India
- GlobMedIndia cancer drugs
👉 Order Now for Fast, Safe & Secure Delivery Across India!
